Molecular Combing Solutions for Entire Genome Analysis

Single DNA molecule analysis & visualization technology

Genomic Vision is a biotechnology company that fulfills unmet needs by developing and commercializing novel molecular genetic tests and research tools in life sciences for:

Large scale genome modifications in multiple sites are known to be significant in human polymorphisms, cancer and genetic diseases and are frequently masked or inaccurately detected by current technologies.

By using Molecular Combing, a proprietary single DNA molecule analysis technology, Genomic Vision provides access to an easy and accurate way to visualize DNA rearrangements at multiples sites throughout the whole genome.

Our mission is to create new standards in disease genetic testing and health care management for more efficient, individualized, predictive and preventive medicine.

Learn more about:

Newsletter

Subscribe to Genomic Vision newsletter :

Read the latest newsletter from Genomic Vision

Events

Genomic Vision’s breakthrough technology will change the way you analyze DNA.

FSHDCombing test is our new molecular genetic test for the Facio Scapulo Humeral Disease.